Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals

International Journal of STD and AIDS

Volumn 20, Issue 5, 2009, Pages 336-338

  Ramezani, A ^a,c   Mohraz, M ^a   Aghakhani, A ^a   Banifazl, M ^a   Eslamifar, A ^a   Khadem Sadegh, A ^a   Velayati, A A ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Hepatitis C virus; HIV; Isolated hepatitis B core antibody

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS DNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORBIDITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD;

ADULT; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS C; HIV INFECTIONS; HUMANS; IRAN; MALE;

EID: 66349124840     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008377     Document Type: Article

References (30)

1. Seddigh-Tonekaboni S, Waters JA, Jeffers S, et al. Effect of variation in the common 'a' determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 2000;60:113-121
2. 2 Weinberger KM, Bauer T, Bohm S, Jilg W. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000;81:1165-1174 (Pubitemid 30232700)
3. Grob P, Jilg W, Bornhak H, et al. Serological pattern 'anti-HBc alone': report on a workshop. J Med Virol 2000;62:450-455
4. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 2001;34:194-203
5. Conjeevaram HS, Lok AS. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001;34:204-206
6. 6 Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang 2004;86:83-91 (Pubitemid 38436885)
7. Jardi R, Rodriguez F, Buti M, et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404-410
8. 8 Neau D, Winnock M, Galperinep T, et al. Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patients. HIV Med 2004;5:171-173 (Pubitemid 38765284)
9. Gandhi RT, Wurcel A, Lee H. Isolated antibody to hepatitis B core antigen in HIV-infected individuals. Clin Infect Dis 2003;36:1602-1605
10. Jilg W, Sieger E, Zachoval R, Schatzl H. Individual with antibodies against hepatitis B core antigen: high percentage of carriers of hepatitis B and C virus. J Hepatol 1995;23:14-20
11. 11 Greub G, Frei PC. Isolated antibody to Hepatitis B core is associated with hepatitis C virus infection. Clin Microbiol Infect 2000;6:629 (Pubitemid 34966084)
12. Berger A, Doerr HW, Rabenau HF, Weber B. High frequency of HCV infection in individuals with isolated antibody to hepatitis B core antigen. Intervirology 2000;43:71-76
13. 13 Wedemeyer H, Cornberg M, Tegtmeyer B, Frank H, Tillman HL, Manns MP. Isolated anti-HBV core phenotype in anti-HCV positive patients is associated with hepatitis C virus replication. Clin Microbiol Infect 2004;10:70-72 (Pubitemid 38128594)
14. 14 Wiedman M, Liebert UG, Oeson U, et al. Decreased immunogenicity of recombitant hepatitis B vaccine in chronic hepatitis C. Hepatology 2000;31:230-234 (Pubitemid 30033712)
15. 15 French AL, Operskalski E, Peters M, et al. Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women. J Infect Dis 2007;195:1437-1442 (Pubitemid 46717461)
16. Piroth L, Lafon ME, Binquet C, et al. Occult hepatitis B in HIV-HCV coinfected patients. Scand J Infect Dis 2008;31:1-5
17. 17 Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 2001;64:312-319 (Pubitemid 32565127)
18. 18 Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988;8:766-770 (Pubitemid 18205027)
19. 19 Piroth L, Binquet C, Vergne M, et al. The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients. J Hepatol 2002;36:681-686 (Pubitemid 34499406)
20. 20 Jongjirawisan Y, Ungulkraiwit P, Sungkanuparph S. Isolated antibody to hepatitis B core antigen in HIV-1 infected patients and a pilot study of vaccination to determine the anamnestic response. J Med Assoc Thai 2006;89:2028-2034 (Pubitemid 44956681)
21. 21 Davaro RE, Cheeseman SH, Keroack MA, Ellison RT. The significance of isolated antibody to hepatitis B core antigen seropositivity in patients infected with human immunodeficiency virus. Clin Infect Dis 1996;23:189-190 (Pubitemid 26323824)
22. Neau D, Winnock M, Jouvencel AC, et al. Occult hepatitis B virus infection in HIV-infected patients with isolated antibodies to hepatitis B core antigen: Aquitaine cohort, 2002-2003. Clin Infect Dis 2005;40:750-753
23. Nunez M, Rios P, Perez-Olmeda M, Soriano V. Lack of 'occult' hepatitis B virus infection in HIV-infected patients. AIDS 2002;16:2099-2101
24. 24 Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV Cohort Study. Eur J Clin Microbiol Infect Dis 1998;17:6-13 (Pubitemid 28072282)
25. 25 Santos EA, Yoshida CF, Rolla VC, et al. Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 2003;22:92-98 (Pubitemid 36349970)
26. 26 Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999;341:22-26 (Pubitemid 29293716)
27. Laguno M, Larrousse M, Blanco JL, et al. Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients. AIDS Res Hum Retroviruses 2008;24:547-553
28. 28 Squadrito G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer 2006;106:1326-1330 (Pubitemid 43363910)
29. Ikeda K, Marusawa H, Osaki Y, et al. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study. Ann Intern Med 2007;146:649-656
30. Vitale F, Tramuto F, Orlando A, et al. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J Med Virol 2008;80:577-582